AN ESSENTIAL ROLE FOR GP39, THE LIGAND FOR CD40, IN THYMIC SELECTION

被引:144
作者
FOY, TM
PAGE, DM
WALDSCHMIDT, TJ
SCHONEVELD, A
LAMAN, JD
MASTERS, SR
TYGRETT, L
LEDBETTER, JA
ARUFFO, A
CLASSEN, E
XU, JCC
FLAVELL, RA
OEHEN, S
HEDRICK, SM
NOELLE, RJ
机构
[1] DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756
[2] UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093
[3] UNIV IOWA,COLL MED,DEPT PATHOL,IOWA CITY,IA 52242
[4] TNO,DEPT IMMUNOL & MED MICROBIOL,MED BIOL LAB,RIJSWIJK,NETHERLANDS
[5] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
[6] YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510
关键词
D O I
10.1084/jem.182.5.1377
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interactions between CD40 on B cells and its ligand gp39 on activated T helper cells are known to be essential for the development of thymus-dependent humoral immunity. However, CD40 is also functionally expressed on thymic epithelial cells and dendritic cells, suggesting that gp39-CD40 interactions may also play a role in thymic education, the process by which self-reactive cells are deleted from the T cell repertoire. Six systems of negative selection were studied for their reliance on gp39-CD40 interactions to mediate negative selection. In all cases, when the antigen/superantigen was endogenously expressed (in contrast to exogenously administered), negative selection was blocked by loss of gp39 function. Specifically, blockade of gp39-CD40 interactions prevented the deletion of thymocytes expressing V beta 3, V beta 11, and V beta 12, specificities normally deleted in BALB/c mice because of the endogenous expression of minor lymphocyte-stimulating determinants. Independent verification of a role of gp39 in negative selection was provided by studies in gp39-deficient mice where alterations in T cell receptor (TCR) VP expression were also observed. Studies were also performed in the AND TCR transgenic (Tg) mice, which bear the V alpha 11, V beta 3 TCR and recognize both pigeon cytochrome c (PCC)/IE(k) and H-2A(s). Neonatal administration of anti-gp39 to AND TCR Tg mice that endogenously express H-2A(s) or endogenously produce PCC prevented the deletion of TCR Tg T cells. In contrast, deletion mediated by high-dose PCC peptide antigen (administered exogenously) in AND TCR mice was unaltered by administration of anti-gp39. In addition, deletion by Staphylococcus enterotoxin B in conventional mice was also unaffected by anti-gp39 administration. gp39 expression was induced on thymocytes by mitogens or by antigen on TCR Tg thymocytes. Immunohistochemical analysis of B7-2 expression in the thymus indicated that, in the absence of gp39, B7-2 expression was substantially reduced. Taken together, these data suggest that gp39 may influence negative selection through the regulation of costimulatory molecule expression. Moreover, the data support the hypothesis that, for negative selection to some endogenously produced antigens, negative selection may be dependent on TCR engagement and costimulation.
引用
收藏
页码:1377 / 1388
页数:12
相关论文
共 43 条
  • [1] B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28
    AZUMA, M
    ITO, D
    YAGITA, H
    OKUMURA, K
    PHILLIPS, JH
    LANIER, LL
    SOMOZA, C
    [J]. NATURE, 1993, 366 (6450) : 76 - 79
  • [2] CARLOW DA, 1992, J IMMUNOL, V148, P1595
  • [3] CAYABYAB M, 1994, J IMMUNOL, V152, P1523
  • [4] CHENEY RT, 1985, TRANSPLANT P, V17, P528
  • [5] LIGATION OF B7 WITH CD28 CTLA-4 ON T-CELLS RESULTS IN CD40 LIGAND EXPRESSION, INTERLEUKIN-4 SECRETION AND EFFICIENT HELP FOR ANTIBODY-PRODUCTION BY B-CELLS
    DEBOER, M
    KASRAN, A
    KWEKKEBOOM, J
    WALTER, H
    VANDENBERGHE, P
    CEUPPENS, JL
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3120 - 3125
  • [6] DEGERMANN S, 1994, J IMMUNOL, V152, P3254
  • [7] THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY
    DURIE, FH
    FOY, TM
    MASTERS, SR
    LAMAN, JD
    NOELLE, RJ
    [J]. IMMUNOLOGY TODAY, 1994, 15 (09): : 406 - 411
  • [8] FINE JS, 1992, J IMMUNOL, V147, P2852
  • [9] Foy T M, 1994, Semin Immunol, V6, P259, DOI 10.1006/smim.1994.1034
  • [10] GALY AHM, 1992, J IMMUNOL, V149, P775